Experience Sampling Method in OAB Patients
NCT03435991 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 132
Last updated 2020-02-21
Summary
Rationale: The overactive bladder syndrome is diagnosed clinically by using the ICS criteria of ≥8 micturitions and at least 1 urgency episode per 24 hours. To determine whether patients fit the criteria, micturition diaries ('sensation-related bladder diaries') and other symptom questionnaires with considerable limitations are used. This makes it difficult to get a good impression of the fluctuation of complaints during the day / week. These limitations are overcome using the Experience Sampling Method (ESM). This is an electronic questioning method which is characterized by repeated and random, momentary assessments in the subject's current environment and state. This study follows other successful ESM studies done within the Gastroenterology and Psychiatry Department. The aim of this study is to evaluate if the ESM is more accurate in the assessment of urological complaints in OAB compared to the current assessment with the use of the sensations-related bladder diaries (SR-BDs) and retrospective questionnaires. Furthermore the aim is to assess the reliability and validity of this OAB-specific electronic patient-reported outcome measure (ePRO), based on the Experience Sampling Method-principle, for symptom assessment and assessment of triggers for symptoms in OAB.
Objective: To evaluate the accuracy of the ESM to assess urological complaints in OAB compared to SR-BDs and retrospective questionnaires. To assess content validity, reliability and the accuracy to validate the developed ePRO in OAB patients.
Study design: The ESM study is a multicentre, prospective, cross-sectional study.
Study population: 66 OAB patients will be recruited at the outpatient Pelvic Care Centre in Maastricht UMC+, Zuyderland Hospital and University Hospital Antwerp, 66 healthy volunteers will be recruited as well.
Methods: In a period of 7 days, participants will fill out an electronic ESM assessment at 10 random moments during the day. Moreover, they will fill out a sensation-related bladder diary (SR-BD) during the last three consecutive days of filling out the ESM and several symptom questionnaires at the end of the study period.
Main study endpoints: The main study outcome comprehends the psychometric properties of the PROM for symptom assessment of OAB symptoms. Secondary outcomes are increase in ESM score for OAB symptoms and environmental and psychosocial factors (e.g. as measured by the PROM) from one time point (t-1) to the next (t).
Conditions
- Overactive Bladder
- Overactive Bladder Syndrome
Interventions
- OTHER
-
Validation Experience Sampling Method 'Uromate'
In a period of 7 days, participants will fill out an electronic ESM assessment at 10 random moments during the day. Moreover, they will fill out a sensation-related bladder diary (SR-BD) during the last three consecutive days of filling out the ESM and several symptom questionnaires at the end of the study period.
Sponsors & Collaborators
-
Zuyderland Hospital
collaborator UNKNOWN -
University Hospital, Antwerp
collaborator OTHER -
Maastricht University Medical Center
lead OTHER
Principal Investigators
-
Desiree Vrijens, MD, PhD · Maastricht University Medical Center
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2018-08-06
- Primary Completion
- 2021-01-05
- Completion
- 2021-01-05
Countries
- Netherlands
Study Locations
More Related Trials
-
Pilot Trial in Sleep Laboratory Setting to Compare the Physiology of Night Time Bladder Function in Subjects With Overactive Bladder (OAB) Versus Subjects That Have Insomnia and Healthy Normal Subjects
NCT01029015 ·Status: COMPLETED
-
Effects Of GW679769 On Bladder Nerve Function And Symptoms Of Overactive Bladder In Spinal Cord Injury Patients
NCT00332319 ·Status: TERMINATED ·Phase: PHASE2
-
Urge Incontinence Bladder Overactivity Study
NCT00475696 ·Status: COMPLETED ·Phase: PHASE2
-
Assessing the OAB-8 Questionnaire as a Tool to Measure Treatment Outcome
NCT00313924 ·Status: UNKNOWN ·Phase: PHASE4
-
BlueWind RENOVA iStim™ System for the Treatment of OAB
NCT03596671 ·Status: COMPLETED ·Phase: NA
-
Assessment of Patient-reported Goal Attainment in the Treatment of Female Overactive Bladder
NCT00836381 ·Status: COMPLETED ·Phase: PHASE4
-
Desmopressin Melt Therapy in Patients With Nocturnal Polyuria: a Pharmacokinetic/Dynamic Study
NCT01435083 ·Status: COMPLETED ·Phase: PHASE4
-
A Pilot Trial in a Sleep Laboratory Setting to Observe Night Time Bladder Function of Subjects With Overactive Bladder (OAB)
NCT01099345 ·Status: TERMINATED
-
Developing a Simple Test to Diagnose Overactive Bladder
NCT05572918 ·Status: UNKNOWN
-
Higher Neural Changes Following Anticholinergic, Beta 3 Agonist, or Placebo in Patients With Overactive Bladder
NCT03817931 ·Status: COMPLETED ·Phase: PHASE4
-
Bladder Diary for Diagnosing Bladder Oversensitivity
NCT04981015 ·Status: COMPLETED
-
A Study Measuring and Tracking Changes in Overactive Bladder (OAB) Medication
NCT01317810 ·Status: WITHDRAWN
-
A Study to Evaluate the Efficacy of Tolterodine on Specific Symptoms in Adult Patients With Overactive Bladder.
NCT00645281 ·Status: COMPLETED ·Phase: PHASE4
-
Combined Behavioral and Drug Treatment of Overactive Bladder in Men
NCT01175382 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
InSite for Over Active Bladder
NCT00547378 ·Status: COMPLETED ·Phase: PHASE4
-
Validation of a Real-time Urodynamic Measure of Urinary Urgency
NCT00909428 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy, Tolerability and Impact on Quality of Life of Propiverine in Patients With Overactive Bladder Syndrome
NCT02024945 ·Status: COMPLETED
-
Comparison of Caffeine Reduction and Anticholinergic Medications for Treatment of Overactive Bladder
NCT00780832 ·Status: TERMINATED ·Phase: NA
-
OnabotulinumtoxinA Bladder Injection Study
NCT03523091 ·Status: TERMINATED ·Phase: PHASE4
-
A Study on Anticholinergic Use: Attribution of Overactive Bladder (OAB) Medications to the Anticholinergic Burden
NCT03903094 ·Status: COMPLETED
-
Comparing Number of Injection Sites of In-office Intravesical Onabotulinumtoxin A Treatments for Overactive Bladder: A Randomized Controlled Trial
NCT05157295 ·Status: UNKNOWN ·Phase: PHASE4
-
An Extension Study to Examine the Safety and Tolerability of a New Drug in Patients With Symptoms of Overactive Bladder (OAB).
NCT03583372 ·Status: COMPLETED ·Phase: PHASE3
-
Treatment of the Overactive Bladder Syndrome: A Delphi Study
NCT04300400 ·Status: COMPLETED
-
A Prospective, Observational, Multicenter Study of Patients Following Initiation of a New Course of Treatment for Overactive Bladder (OAB)
NCT02386072 ·Status: COMPLETED
-
Effect of Detrol LA on Overactive Bladder Symptoms, Sexual Quality of Life and Sexual Function in Women
NCT00143481 ·Status: COMPLETED ·Phase: PHASE4